Dimethyl Fumarate as Therapeutic Alternative in Moderate-to-Severe Psoriasis: Our Experience
Pau Rosés Gibert, Francisco Javier de la Torre Gomar, Amaia Saenz Aguirre, Javier Gimeno Castillo, Ricardo González Pérez Dermatology Department, Araba University Hospital, Vitoria-Gasteiz, SpainCorrespondence: Pau Rosés Gibert, Araba University Hospital, Jose Atxotegi Kalea, s/n, Vitoria-Gasteiz, A...
Saved in:
Main Authors: | Rosés Gibert P (Author), de la Torre Gomar FJ (Author), Saenz Aguirre A (Author), Gimeno Castillo J (Author), González Pérez R (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2022-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dimethyl fumarate titration for the systemic treatment of moderate-to-severe plaque psoriasis
by: Giovanna Malara, et al.
Published: (2021) -
Dimethyl Fumarate Treatment in Patients with Moderate-to-Severe Psoriasis: A 52-week Real-life Study
by: Laura Gnesotto, et al.
Published: (2023) -
Effect of dimethyl fumarate in patients with plaque psoriasis meeting the upgrade criteria required for moderate‐to‐severe disease classification
by: Sascha Gerdes, et al.
Published: (2024) -
Therapeutic Effects of Dimethyl Fumarate on the Rat Model of Brain Ischemia
by: Maryam Owjfard, et al.
Published: (2022) -
Estudio descriptivo de los pacientes diagnosticados de melanoma en la provincia de Álava (País Vasco) entre los años 2015 y 2018
by: P. Rosés-Gibert, et al.
Published: (2022)